The fidelity of protein synthesis, a process shaped by several mechanisms involving specialized ribosome regions and external factors, ensures the precise reading of sense and stop codons. However, premature termination codons (PTCs) arising from mutations may, at low frequency, be misrecognized and result in PTC suppression, named ribosome readthrough, with production of full-length proteins through the insertion of a subset of amino acids. Since some drugs have been identified as readthrough inducers, this fidelity drawback has been explored as a therapeutic approach in several models of human diseases caused by nonsense mutations. Here, we focus on the mechanisms driving translation in normal and aberrant conditions, the potential fates of mRNA in the presence of a PTC, as well as on the results obtained in the research of efficient readthrough-inducing compounds. In particular, we describe the molecular determinants shaping the outcome of readthrough, namely the nucleotide and protein context, with the latter being pivotal to produce functional full-length proteins. Through the interpretation of experimental and mechanistic findings, mainly obtained in lysosomal and coagulation disorders, we also propose a scenario of potential readthrough-favorable features to achieve relevant rescue profiles, representing the main issue for the potential translatability of readthrough as a therapeutic strategy.

Lombardi, S., Francesca Testa, M., Pinotti, M., Branchini, A. (2020). Molecular Insights into Determinants of Translational Readthrough and Implications for Nonsense Suppression Approaches. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 21(24), 1-25 [10.3390/ijms21249449].

Molecular Insights into Determinants of Translational Readthrough and Implications for Nonsense Suppression Approaches

Silvia Lombardi
Co-primo
;
2020

Abstract

The fidelity of protein synthesis, a process shaped by several mechanisms involving specialized ribosome regions and external factors, ensures the precise reading of sense and stop codons. However, premature termination codons (PTCs) arising from mutations may, at low frequency, be misrecognized and result in PTC suppression, named ribosome readthrough, with production of full-length proteins through the insertion of a subset of amino acids. Since some drugs have been identified as readthrough inducers, this fidelity drawback has been explored as a therapeutic approach in several models of human diseases caused by nonsense mutations. Here, we focus on the mechanisms driving translation in normal and aberrant conditions, the potential fates of mRNA in the presence of a PTC, as well as on the results obtained in the research of efficient readthrough-inducing compounds. In particular, we describe the molecular determinants shaping the outcome of readthrough, namely the nucleotide and protein context, with the latter being pivotal to produce functional full-length proteins. Through the interpretation of experimental and mechanistic findings, mainly obtained in lysosomal and coagulation disorders, we also propose a scenario of potential readthrough-favorable features to achieve relevant rescue profiles, representing the main issue for the potential translatability of readthrough as a therapeutic strategy.
Articolo in rivista - Review Essay
Nonsense mutations; Premature termination codons; Ribosome readthrough;
English
2020
21
24
1
25
9449
none
Lombardi, S., Francesca Testa, M., Pinotti, M., Branchini, A. (2020). Molecular Insights into Determinants of Translational Readthrough and Implications for Nonsense Suppression Approaches. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 21(24), 1-25 [10.3390/ijms21249449].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/413557
Citazioni
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 9
Social impact